He Wei-Wu

13D and 13G Filings

13D/G filings: 13D on 1 security
CIK: 0001542073
All SEC filings: View on sec.gov

Issuer	Symbol	CUSIP	% of Class	Shares	Form	Filed
CASI Pharmaceuticals, Inc. 13D/A Amendment 15 CASIF · G1933S101	CASIF	G1933S101	58.8%	23,985,535	13D/A Amendment 15	5/18/2026 Event 5/18/2026
WEI-WU HE, Ph.D.			58.8%	23,985,535
Huiying Memorial Foundation			3.1%	637,644
Emerging Technology Partners, LLC			52.0%	21,097,341
ETP Global Fund L.P.			3.7%	753,234
Etp Biohealth III Fund, L.P.			1.5%	300,000
HE Family GRAT			0.5%	100,000
ETP Global III Fund L.P.			49.3%	20,000,000
CASI Pharmaceuticals, Inc. 13D/A Amendment 14 CASIF · G1933S101	CASIF	G1933S101	53.0%	18,985,535	13D/A Amendment 14	3/23/2026 Event 3/23/2026
WEI-WU HE, Ph.D.			53.0%	18,985,535
Huiying Memorial Foundation			3.1%	637,644
Emerging Technology Partners, LLC			45.3%	16,097,341
ETP Global Fund L.P.			3.7%	753,234
Etp Biohealth III Fund, L.P.			1.5%	300,000
HE Family GRAT			0.5%	100,000
ETP Global III Fund L.P.			42.2%	15,000,000
CASI Pharmaceuticals, Inc. 13D/A Amendment 13 CASIF · G1933S101	CASIF	G1933S101	45.4%	13,965,535	13D/A Amendment 13	2/10/2026 Event 2/9/2026
WEI-WU HE, Ph.D.			45.4%	13,965,535
Huiying Memorial Foundation			3.1%	637,644
Emerging Technology Partners, LLC			5.3%	1,097,341
ETP Global Fund L.P.			3.7%	753,234
Etp Biohealth III Fund, L.P.			1.5%	300,000
HE Family GRAT			0.5%	100,000
ETP Global Fund III L.P.			32.7%	10,000,000
CASI Pharmaceuticals, Inc. 13D/A Amendment 12 CASIF · G1933S101	CASIF	G1933S101	34.8%	8,965,535	13D/A Amendment 12	1/29/2026 Event 1/27/2026
WEI-WU HE, Ph.D.			34.8%	8,965,535
Huiying Memorial Foundation			3.1%	637,644
Emerging Technology Partners, LLC			5.3%	1,097,341
ETP Global Fund L.P.			3.7%	753,234
Etp Biohealth III Fund, L.P.			1.5%	300,000
HE Family GRAT			0.5%	100,000
ETP Global Fund III L.P.			19.6%	5,000,000
CASI Pharmaceuticals, Inc. 13D/A Amendment 11 CASIF · G1933S101	CASIF	G1933S101	19.1%	3,965,535	13D/A Amendment 11	1/9/2026 Event 1/9/2026
WEI-WU HE, Ph.D.			19.1%	3,965,535
Huiying Memorial Foundation			3.1%	637,644
Emerging Technology Partners, LLC			5.3%	1,097,341
ETP Global Fund L.P.			3.7%	753,234
Etp Biohealth III Fund, L.P.			1.5%	300,000
HE Family GRAT			0.5%	100,000
CASI Pharmaceuticals, Inc. 13D/A Amendment 10 CASIF · G1933S101	CASIF	G1933S101	19.1%	3,965,535	13D/A Amendment 10	12/18/2025 Event 12/18/2025
WEI-WU HE, Ph.D.			19.1%	3,965,535
Huiying Memorial Foundation			3.1%	637,644
Emerging Technology Partners, LLC			5.3%	1,097,341
ETP Global Fund L.P.			3.7%	753,234
Etp Biohealth III Fund, L.P.			1.5%	300,000
HE Family GRAT			0.5%	100,000
CASI Pharmaceuticals, Inc. 13D/A Amendment 9 CASIF · G1933S101	CASIF	G1933S101	23.8%	3,735,535	13D/A Amendment 9	6/20/2025 Event 6/16/2025
WEI-WU HE, Ph.D.			23.8%	3,735,535
Huiying Memorial Foundation			2.6%	407,644
Emerging Technology Partners, LLC			7.1%	1,097,341
ETP Global Fund L.P.			4.9%	753,234
Etp Biohealth III Fund , L.P.			1.9%	300,000
HE Family GRAT			0.6%	100,000

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.